Aspect Biosystems

$79,000,000.00 CAD

≈ $1.91 for every person in Canada ≈ 1,021 Canadians' average pay for a year

Department: Innovation, Science and Economic Development Canada
Program: Strategic Response Fund
Recipient country: Canada
Fiscal year: 2025-2026
Agreement period: January 9, 2026 – July 31, 2050
Reference: ic:033-2025-2026-Q4-820313

Published purpose

This project will commercialize bioprinted tissue therapeutics, expand AI-enabled bioprinting and cell engineering capabilities, and establish a commercial-scale Current Good Manufacturing Practice biomanufacturing facility with end-to-end automation. The project’s work phase is scheduled to end on March 31, 2031.

In plain English AI-generated

This project supports Aspect Biosystems Ltd. in commercializing bioprinted tissue therapeutics, expanding AI-enabled bioprinting and cell engineering, and building a commercial-scale biomanufacturing facility in Canada.

Category: Health Primarily funds activity in Canada

Based on the published description. See how AI categorization works — the linked official record is authoritative.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful

View official source record Imported August 3, 2026 from open.canada.ca Grants & Contributions